with earlier ndings by Honjo and co-workers, 4 who rst documented TI IgA CSR in the mouse LP. In spite of this evidence, the contribution of the LP to intestinal IgA production remains controversial. 5 -7 Prior studies have generated a consensus over the existence of an IgA-inductive site represented by the organized lymphoid tissue of PPs and an IgA e ector site represented by the non-organized lymphoid cells of the LP (reviewed in ref. 1) . PPs typically give rise to monoreactive IgA antibodies with high a nity for TD antigens, such as complex proteins. is TD IgA response occurs in the GC of PPs and requires engagement of CD40 on conventional IgM + B cells (known as B-2 in mice) by CD40 ligand (CD40L) on CD4 + T-helper cells. Signals from CD40 lead to upregulation of AID, a DNA-editing enzyme essential for Ig gene diversi cation by CSR and somatic hypermutation. 8 In general, CSR diversi es the antibody e ector functions by substituting the heavy-chain constant region of IgM and IgD with that of IgG, IgA, or IgE, whereas somatic hypermutation introduces point mutations in the variable genes encoding the antigenbinding portion of Igs, thereby providing the structural correlate for selection by antigen of higher a nity mutants.
In PPs, CSR is predominantly skewed toward IgA, possibly as a result of the intrinsic in uence of their microenvironment (reviewed in ref. 1). Indeed, PPs contain abundant cytokines involved in IgA CSR and secretion, including interleukin (IL)-6, IL-10, and transforming growth factor-. 9 By upregulating guthoming receptors and under the in uence of epithelial chemotactic factors, IgA + B cells migrate from PPs to the LP and thereafter differentiate into plasmablasts, which secrete large amounts of Immunoglobulin (Ig)A constitutes the most abundant antibody in the gut, where it provides immune protection through both high-and low-affinity binding systems (reviewed in ref. Unlike mouse B cells, which express only one IgA class, human B cells express two IgA subclasses. e large intestine contains predominantly IgA2, which is more resistant to digestion by bacteria than IgA1. We found that human colonocytes release the cytokine a proliferation-inducing ligand (APRIL), a er sensing bacteria through Toll-like receptors. 2 
APRIL triggers direct
IgM-to-IgA2 class switch DNA recombination (CSR) and sequential IgA1-to-IgA2 CSR in LP B cells through a T-cell-independent (TI) mechanism that requires transcriptional activation of the C 2 gene and subsequent expression of activationinduced cytidine deaminase (AID), a key component of the CSR machinery. Our data strongly suggest that epithelial cells utilize APRIL to enhance local production of protease-resistant IgA2, which is more suited than IgA1 to cope with the dense microbial community of the large intestine ( 12 show that intestinal dendritic cells sample lumenal antigens through transepithelial projections. Such sampling activity likely results in Toll-like receptor-dependent upregulation of innate IgA CSR-inducing factors, including APRIL and its homologue B-cell-activating factor of the tumor necrosis factor family (BAFF, also known as BLyS). 2, 13 Although lacking canonical B-1 cells, human B cells undergo CD40-independent IgA CSR upon exposure to BAFF and APRIL. 14 ese TI stimuli may be more prominent than originally anticipated, as up to 10 % of patients with common variable immunode ciency or selective IgA de ciency exhibit defective signaling via transmembrane activator and calcium modulator and cyclophylin ligand interactor, a BAFF and APRIL receptor expressed by B cells. 15, 16 Conversely, patients with hyper-IgM syndrome caused by CD40 signaling defects show conserved systemic and / or mucosal IgA responses. 2, 17 Yet, these patients lack functional GCs, suggesting that humans, like mice, have developed extrafollicular pathways for TI IgA production. e human B-cell types involved in TI IgA responses remain to be identi ed, but may include IgM memory B cells, which make mutated antibodies against bacterial polysaccharides, as well as transitional B cells, which make unmutated antibodies against multiple antigenic speci cities. 18, 19 Ongoing studies in our lab are exploring the gut-homing properties of these B-cell subsets.
The following observations indicate that the intestinal LP can serve as an IgAinductive site in both mice and humans. First, the LP contains IgM + B cells that 
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can further switch to IgA under the in uence of powerful B-cell-stimulating factors released by epithelial cells, dendritic cells, and stromal cells, including BAFF and APRIL. 2, 20 Most of these IgM + B cells likely derive from PPs, isolated lymphoid follicles, and mesenteric lymph nodes, whereas others may originate from the peritoneal cavity and the bone marrow (reviewed in ref. 1) . Second, the LP contains IgA + B cells bearing hallmarks of active IgA CSR, including AID and postdeletional switch circle transcripts, as reported independently by three groups in different experimental systems. 2 -4 Third, the presence of IgA CSR and AID in the LP is in agreement with growing evidence showing that AIDdependent diversi cation of Ig genes is not restricted to the GC, but also occurs in extrafollicular areas, including the mucosal subepithelium. 13, 21 Unlike other groups, 2 -4 Kiyono, Spencer, and Lycke ' s groups 5 -7 could not detect AID and IgA switch circle transcripts in mouse or human LP B cells. Discrepancies might be due to the demanding nature of the experiments required for the identification of AID and switch circle transcripts. Indeed, these experiments need to circumvent poor cellular yields and low amounts of speci c CSRassociated transcripts. e fact that the mouse gut contains a less abundant and diverse micro ora than the human gut may account for the di erences between species. Additional di erences may originate from the fact that the small intestine, which is o en studied in mice, is less exposed to bacteria and may therefore contain less IgA class-switching LP B cells than the large intestine. Another important consideration relates to the possible existence of multiple mucosal microcompartments for TI IgA production, including the perifollicular areas of PPs and mesenteric lymph nodes. These sites may become predominant under speci c experimental conditions. Finally, it must be noted that, Spencer and Lycke ' s groups 6,7 although unable to detect AID and switch circle transcripts, detected germline C transcripts in LP B cells. ese transcripts are much more abundant than switch circle transcripts and are usually associated with ongoing IgA CSR.
By ensuring the establishment of complex commensal and symbiotic relationships, co-evolution of mammals and bacteria over the past 200 million years has contributed to the development of multiple follicular and extrafollicular layers of protection in the intestinal mucosa. By documenting IgA class switching in the LP, recent studies have identified an additional extrafollicular layer and blurred the distinction between sites of adaptive response induction and deployment of effector activities. 2 -4 While PPs, isolated lymphoid follicles, and mesenteric lymph nodes must be certainly regarded as major inductive sites for TD production of high-a nity IgA against pathogens, the LP as well as other as yet undefined compartments could account for TI production of low-a nity IgA against commensals and dietary antigens. Further studies are warranted to understand better the composition and regulation of each mucosal site and its relative contribution to the induction of mono-and polyspeci c IgA responses.
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